Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Turner

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|June 6, 2020
Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug responseDaniel F Carr, Richard M Turner, Munir Pirmohamed
British Journal of Clinical Pharmacology|March 29, 2022
Pharmacogenomics: Relevance and opportunities for clinical pharmacologyRichard M Turner, Emma F Magavern, Munir Pirmohamed
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|May 8, 2015
Parsing interindividual drug variability: an emerging role for systems pharmacologyRichard M Turner, B Kevin Park, Munir Pirmohamed
European Journal of Clinical Pharmacology|April 15, 2022
A European cross-sectional survey to investigate how involved doctors training in clinical pharmacology are in drug concentration monitoringThomas J Green, Lauren E Walker, Richard M Turner
The Pharmacogenomics Journal|March 5, 2024
Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?Benjamin Cross, Richard M Turner, J Eunice Zhang, et al.
Journal of the American Chemical Society|December 17, 2013
A self-organizing chemical assembly lineAirton G Salles, Salvatore Zarra, Richard M Turner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 27, 2014
Flow chemistry meets advanced functional materialsRebecca M Myers, Daniel E Fitzpatrick, Richard M Turner, et al.
British Journal of Clinical Pharmacology|October 28, 2019
Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary preventionRichard M Turner, Vanessa Fontana, Richard FitzGerald, et al.
Genes|November 4, 2020
A Review of the Important Role of <i>CYP2D6</i> in PharmacogenomicsChristopher Taylor, Ian Crosby, Vincent Yip, et al.
British Journal of Clinical Pharmacology|June 8, 2021
Cardiovascular drugs and COVID-19 clinical outcomes: A living systematic review and meta-analysisInnocent G Asiimwe, Sudeep Pushpakom, Richard M Turner, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|June 6, 2020
Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug responseDaniel F Carr, Richard M Turner, Munir Pirmohamed
British Journal of Clinical Pharmacology|March 29, 2022
Pharmacogenomics: Relevance and opportunities for clinical pharmacologyRichard M Turner, Emma F Magavern, Munir Pirmohamed
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|May 8, 2015
Parsing interindividual drug variability: an emerging role for systems pharmacologyRichard M Turner, B Kevin Park, Munir Pirmohamed
European Journal of Clinical Pharmacology|April 15, 2022
A European cross-sectional survey to investigate how involved doctors training in clinical pharmacology are in drug concentration monitoringThomas J Green, Lauren E Walker, Richard M Turner
The Pharmacogenomics Journal|March 5, 2024
Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?Benjamin Cross, Richard M Turner, J Eunice Zhang, et al.
Journal of the American Chemical Society|December 17, 2013
A self-organizing chemical assembly lineAirton G Salles, Salvatore Zarra, Richard M Turner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 27, 2014
Flow chemistry meets advanced functional materialsRebecca M Myers, Daniel E Fitzpatrick, Richard M Turner, et al.
British Journal of Clinical Pharmacology|October 28, 2019
Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary preventionRichard M Turner, Vanessa Fontana, Richard FitzGerald, et al.
Genes|November 4, 2020
A Review of the Important Role of <i>CYP2D6</i> in PharmacogenomicsChristopher Taylor, Ian Crosby, Vincent Yip, et al.
British Journal of Clinical Pharmacology|June 8, 2021
Cardiovascular drugs and COVID-19 clinical outcomes: A living systematic review and meta-analysisInnocent G Asiimwe, Sudeep Pushpakom, Richard M Turner, et al.
Pageof 4